Home/Filings/4/0001179110-19-000653
4//SEC Filing

Bosley Katrine 4

Accession 0001179110-19-000653

CIK 0001650664other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 4:11 PM ET

Size

5.0 KB

Accession

0001179110-19-000653

Insider Transaction Report

Form 4
Period: 2019-01-08
Bosley Katrine
DirectorPresident and CEO10% Owner
Transactions
  • Sale

    Common Stock

    2019-01-08$25.27/sh12,000$303,2401,204,966 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended.
  • [F2]This transaction was executed in multiple trades at prices ranging from $25.00 to $25.83. The price reported above reflected the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Editas Medicine, Inc.

CIK 0001650664

Entity typeother

Related Parties

1
  • filerCIK 0001592469

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:11 PM ET
Size
5.0 KB